A4571
3-(α-Acetonylbenzyl)-4-hydroxycoumarin sodium salt
≥98%
Synonym(s):
4-Hydroxy-3-(3-oxo-1-phenylbutyl)coumarin
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Linear Formula:
C19H15O4Na
CAS Number:
Molecular Weight:
330.31
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352100
MDL number:
Assay:
≥98%
Form:
powder
Quality Level
assay
≥98%
form
powder
impurities
water, may contain traces, ~8% Isopropanol
SMILES string
[Na].CC(=O)CC(c1ccccc1)C2=C(O)c3ccccc3OC2=O
InChI
1S/C19H16O4.Na/c1-12(20)11-15(13-7-3-2-4-8-13)17-18(21)14-9-5-6-10-16(14)23-19(17)22;/h2-10,15,21H,11H2,1H3;/q;+1/p-1
InChI key
KYITYFHKDODNCQ-UHFFFAOYSA-M
Gene Information
human ... VKORC1(79001)
signalword
Danger
hcodes
Hazard Classifications
Acute Tox. 2 Oral - Aquatic Chronic 3 - Repr. 1B
Storage Class
6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Tse-Yin Huang et al.
Scientific reports, 10(1), 15910-15910 (2020-09-29)
Resveratrol (RVT) has various beneficial bioactivities and popularly used as a dietary supplement. RVT showed inhibitions on CYP1A2/2C9/3A4, breast cancer resistance protein (BCRP), and some conjugated metabolites of RVT also inhibited BCRP. (±)Warfarin, an anticoagulant for cardiovascular disease but with
Wenjing Wang et al.
Journal of biomolecular structure & dynamics, 38(11), 3178-3187 (2019-08-06)
Empagliflozin is an oral sodium glucose co-transporter-2 inhibitor for type 2 diabetes mellitus. The interaction between empagliflozin and human serum albumin (HSA) was investigated experimentally and theoretically. Fluorescence quenching and time-resolved fluorescence spectroscopy indicated that the quenching mechanism of empagliflozin
Catherine K Chang et al.
Journal of vascular surgery, 60(6), 1554-1564 (2014-07-22)
Despite poor long-term patency, acceptable limb salvage has been reported with cryopreserved saphenous vein bypass (CVB) for various indications. However, utility of CVB in patients with critical limb ischemia (CLI) remains undefined. The purpose of this analysis was to determine